Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP607183.RAYYgDO2LH2u5ULZ6wg5H_Die_W-AdZg4RZPar1T2mrGk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP607183.RAYYgDO2LH2u5ULZ6wg5H_Die_W-AdZg4RZPar1T2mrGk130_assertion type Assertion NP607183.RAYYgDO2LH2u5ULZ6wg5H_Die_W-AdZg4RZPar1T2mrGk130_head.
- NP607183.RAYYgDO2LH2u5ULZ6wg5H_Die_W-AdZg4RZPar1T2mrGk130_assertion description "[The prevalence of GADAbs in adulthood patients with type 2 diabetes without insulin therapy is 3-4%, and is higher in the patients with shorter duration of diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607183.RAYYgDO2LH2u5ULZ6wg5H_Die_W-AdZg4RZPar1T2mrGk130_provenance.
- NP607183.RAYYgDO2LH2u5ULZ6wg5H_Die_W-AdZg4RZPar1T2mrGk130_assertion evidence source_evidence_literature NP607183.RAYYgDO2LH2u5ULZ6wg5H_Die_W-AdZg4RZPar1T2mrGk130_provenance.
- NP607183.RAYYgDO2LH2u5ULZ6wg5H_Die_W-AdZg4RZPar1T2mrGk130_assertion SIO_000772 17467104 NP607183.RAYYgDO2LH2u5ULZ6wg5H_Die_W-AdZg4RZPar1T2mrGk130_provenance.
- NP607183.RAYYgDO2LH2u5ULZ6wg5H_Die_W-AdZg4RZPar1T2mrGk130_assertion wasDerivedFrom befree-2016 NP607183.RAYYgDO2LH2u5ULZ6wg5H_Die_W-AdZg4RZPar1T2mrGk130_provenance.
- NP607183.RAYYgDO2LH2u5ULZ6wg5H_Die_W-AdZg4RZPar1T2mrGk130_assertion wasGeneratedBy ECO_0000203 NP607183.RAYYgDO2LH2u5ULZ6wg5H_Die_W-AdZg4RZPar1T2mrGk130_provenance.